Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
CATHERINE A ALMAZAN
Listed Specialty: Family Medicine
201 N CLYDE MORRIS BLVD, SUITE 200, DAYTONA BEACH, FL, 32114-2724
DR. CATHERINE ALMAZAN,
Yearly Payment Breakdown:
2018 Payments At a Glance
21
payments
$277
payment total
12
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
Category | Payments | Payment Value |
---|---|---|
Food and Beverage |
21 | $277 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
Product Name | Product Type | Payments† |
---|---|---|
XIFAXAN |
drug |
$49 |
RELISTOR |
drug |
$33 |
TRESIBA |
drug |
$29 |
VICTOZA |
drug |
$29 |
PREVNAR 13 |
drug |
$24 |
TRULICITY |
drug |
$23 |
VIBERZI |
drug |
$17 |
XULTOPHY 100/3.6 |
drug |
$16 |
REPATHA |
drug |
$15 |
SYMBICORT |
drug |
$14 |
FARXIGA |
drug |
$13 |
VRAYLAR |
drug |
$13 |
INVOKAMET |
drug |
$12 |
INVOKANA |
drug |
$12 |
XARELTO |
drug |
$12 |
OZEMPIC |
drug |
$12 |
SOLIQUA |
drug |
$12 |
JARDIANCE |
drug |
$12 |
BASAGLAR |
drug |
$12 |
VYVANSE |
drug |
$12 |
TOUJEO |
drug |
$11 |
TRELEGY ELLIPTA |
drug |
$11 |
SYMPROIC |
drug |
$11 |
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. |
Payment Details in 2018
When | How Much | Related To | What For | From | Third Party Payee |
---|---|---|---|---|---|
Apr 24, 2018 | $17 | VIBERZI | Food and Beverage | ALLERGAN INC. | |
Dec 24, 2018 | $16 | XIFAXAN | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
Feb 6, 2018 | $16 | XIFAXAN RELISTOR | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
Jun 11, 2018 | $16 | XIFAXAN RELISTOR | Food and Beverage | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
May 1, 2018 | $16 | VICTOZA TRESIBA XULTOPHY 100/3.6 | Food and Beverage | NOVO NORDISK INC | |
Jan 16, 2018 | $15 | REPATHA | Food and Beverage | AMGEN INC. | |
Jan 30, 2018 | $14 | SYMBICORT | Food and Beverage | ASTRAZENECA PHARMACEUTICALS LP | |
Jun 19, 2018 | $13 | VICTOZA TRESIBA | Food and Beverage | NOVO NORDISK INC | |
Oct 30, 2018 | $13 | FARXIGA | Food and Beverage | ASTRAZENECA PHARMACEUTICALS LP | |
Mar 7, 2018 | $13 | VRAYLAR | Food and Beverage | ALLERGAN INC. | |
Jan 2, 2018 | $12 | PREVNAR 13 | Food and Beverage | PFIZER INC. | |
Feb 6, 2018 | $12 | XARELTO INVOKANA INVOKAMET | Food and Beverage | JANSSEN PHARMACEUTICALS, INC | |
Oct 16, 2018 | $12 | OZEMPIC | Food and Beverage | NOVO NORDISK INC | |
Jan 9, 2018 | $12 | SOLIQUA | Food and Beverage | SANOFI-AVENTIS U.S. LLC | |
Feb 27, 2018 | $12 | TRULICITY BASAGLAR | Food and Beverage | LILLY USA, LLC | |
Dec 18, 2018 | $12 | TRULICITY JARDIANCE | Food and Beverage | LILLY USA, LLC | |
Oct 25, 2018 | $12 | VYVANSE | Food and Beverage | SHIRE NORTH AMERICAN GROUP INC | |
Nov 13, 2018 | $12 | PREVNAR 13 | Food and Beverage | PFIZER INC. | |
Apr 10, 2018 | $11 | TOUJEO | Food and Beverage | SANOFI-AVENTIS U.S. LLC | |
Jun 26, 2018 | $11 | TRELEGY ELLIPTA | Food and Beverage | GLAXOSMITHKLINE, LLC. | |
Apr 3, 2018 | $11 | SYMPROIC | Food and Beverage | PURDUE PHARMA L.P. |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.